Terms: = Ovarian cancer AND TSHR, hTSHR-I, 7253, ENSG00000165409, MGC75129, LGR3
10 results:
1. Construction of an Immunity and Ferroptosis-Related Risk Score Model to Predict ovarian cancer Clinical Outcomes and Immune Microenvironment.
Wei C; Zhao G; Gao M; Liu Y; Lei P; Cao T
Front Biosci (Landmark Ed); 2023 Jan; 28(1):4. PubMed ID: 36722270
[TBL] [Abstract] [Full Text] [Related]
2. Somatic Mutational Profile of High-Grade Serous ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
[TBL] [Abstract] [Full Text] [Related]
3. The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in cancer Cells.
Chu YD; Yeh CT
Cells; 2020 Jul; 9(7):. PubMed ID: 32698392
[TBL] [Abstract] [Full Text] [Related]
4. Thyrostimulin-tshr signaling promotes the proliferation of NIH:OVCAR-3 ovarian cancer cells via trans-regulation of the EGFR pathway.
Huang WL; Li Z; Lin TY; Wang SW; Wu FJ; Luo CW
Sci Rep; 2016 Jun; 6():27471. PubMed ID: 27273257
[TBL] [Abstract] [Full Text] [Related]
5. Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer.
Seagle BL; Eng KH; Yeh JY; Dandapani M; Schiller E; Samuelson R; Odunsi K; Shahabi S
Sci Rep; 2016 Feb; 6():21591. PubMed ID: 26883286
[TBL] [Abstract] [Full Text] [Related]
6. Coexistence of Graves' disease and unilateral functioning Struma ovarii: a case report.
Sitasuwan T; Hanamornroongruang S; Peerapatdit T; Thongtang N
BMC Endocr Disord; 2015 Nov; 15():68. PubMed ID: 26530865
[TBL] [Abstract] [Full Text] [Related]
7. Hyperplasia in glands with hormone excess.
Marx SJ
Endocr Relat Cancer; 2016 Jan; 23(1):R1-14. PubMed ID: 26407873
[TBL] [Abstract] [Full Text] [Related]
8. Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.
Gyftaki R; Liacos C; Politi E; Liontos M; Saltiki K; Papageorgiou T; Thomakos N; Haidopoulos D; Rodolakis A; Alevizaki M; Bamias A; Dimopoulos A
Int J Gynecol Cancer; 2014 Jun; 24(5):851-6. PubMed ID: 24844218
[TBL] [Abstract] [Full Text] [Related]
9. Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.
Anastasilakis AD; Ruggeri RM; Polyzos SA; Makras P; Molyva D; Campennì A; Gkiomisi A; Balaris C; Fotiadis PP; Tuccari G; Papachatzopoulos S
Metabolism; 2013 Oct; 62(10):1350-6. PubMed ID: 23806737
[TBL] [Abstract] [Full Text] [Related]
10. Autoimmune thyroid disease elicited by NY-ESO-1 vaccination.
Vita R; Guarneri F; Agah R; Benvenga S
Thyroid; 2014 Feb; 24(2):390-4. PubMed ID: 23590991
[TBL] [Abstract] [Full Text] [Related]
